CAMBRIDGE, MA – The first children have gotten Moderna’s COVID-19 vaccine.
It’s part of the pharmaceutical company’s pediatric clinical trial.
About 6,700 children in the U.S. and Canada between the ages of six-months and 11-years-old are participating.
They are getting two doses of the vaccine spaced about 28-days apart as the trial continues some children will be getting a placebo.
The U.S. Food and Drug Administration authorized emergency use of Moderna’s COVID-19 vaccine for adults in December.
The entire study is expected to last 14 months.